Rankings
▼
Calendar
BBLG Q4 2016 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena
BBLG
Bone Biologics Corporation
$2M
Q4 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$5M
EPS (Diluted)
$11.00
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$521,253
Balance Sheet
Total Assets
$973,085
Total Liabilities
$10M
Stockholders' Equity
-$8M
Cash & Equivalents
$620,375
← FY 2016
All Quarters
Q1 2017 →